XO1, which developed a “miracle” antibody, has been bought by global pharma company Janssen Pharmaceuticals (part of the global company Johnson & Johnson). The Cambridge startup’s CEO is Dr Richard Mason, who’s a member of the Cambridge MBA class of 1999 and a Fellow in Health Management at Cambridge Judge.
Read the full article [businessweekly.co.uk]
Brain food 
Compass 
Entrepreneurship 
In the media 
Network 
News 
Reasons why 
The lowdown 
Thinkers
Comments